225 related articles for article (PubMed ID: 33144042)
1. When to start and stop caffeine and why respiratory status matters.
Davis PG
Semin Fetal Neonatal Med; 2020 Dec; 25(6):101175. PubMed ID: 33144042
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic methylxanthine for prevention of apnoea in preterm infants.
Henderson-Smart DJ; De Paoli AG
Cochrane Database Syst Rev; 2010 Dec; 2010(12):CD000432. PubMed ID: 21154344
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic caffeine to prevent postoperative apnea following general anesthesia in preterm infants.
Henderson-Smart DJ; Steer P
Cochrane Database Syst Rev; 2001; (4):CD000048. PubMed ID: 11687065
[TBL] [Abstract][Full Text] [Related]
4. Postoperative caffeine for preventing apnea in preterm infants.
Henderson-Smart DJ; Steer P
Cochrane Database Syst Rev; 2000; 2001(2):CD000048. PubMed ID: 10796287
[TBL] [Abstract][Full Text] [Related]
5. National and international guidelines for neonatal caffeine use: Are they evidenced-based?
Eichenwald EC
Semin Fetal Neonatal Med; 2020 Dec; 25(6):101177. PubMed ID: 33214064
[TBL] [Abstract][Full Text] [Related]
6. Methylxanthine treatment for apnoea in preterm infants.
Henderson-Smart DJ; De Paoli AG
Cochrane Database Syst Rev; 2010 Dec; (12):CD000140. PubMed ID: 21154343
[TBL] [Abstract][Full Text] [Related]
7. Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial.
Schmidt B; Roberts RS; Anderson PJ; Asztalos EV; Costantini L; Davis PG; Dewey D; D'Ilario J; Doyle LW; Grunau RE; Moddemann D; Nelson H; Ohlsson A; Solimano A; Tin W;
JAMA Pediatr; 2017 Jun; 171(6):564-572. PubMed ID: 28437520
[TBL] [Abstract][Full Text] [Related]
8. Childhood respiratory outcomes after neonatal caffeine therapy.
Cheong JLY; Doyle LW
Semin Fetal Neonatal Med; 2020 Dec; 25(6):101158. PubMed ID: 33127315
[TBL] [Abstract][Full Text] [Related]
9. Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity.
Schoen K; Yu T; Stockmann C; Spigarelli MG; Sherwin CM
Paediatr Drugs; 2014 Apr; 16(2):169-77. PubMed ID: 24399614
[TBL] [Abstract][Full Text] [Related]
10. Neurodevelopmental outcomes after neonatal caffeine therapy.
Synnes A; Grunau RE
Semin Fetal Neonatal Med; 2020 Dec; 25(6):101160. PubMed ID: 33121916
[TBL] [Abstract][Full Text] [Related]
11. Influence of prevention of caffeine citrate on cytokine profile and bronchopulmonary dysplasia in preterm infants with apnea.
Kou C; Han D; Li Z; Wu W; Liu Z; Zhang Y; Gao Z
Minerva Pediatr; 2020 Apr; 72(2):95-100. PubMed ID: 30961342
[TBL] [Abstract][Full Text] [Related]
12. [Apnea of prematurity: risk factors and ambulatory treatment with caffeine citrate].
Ducrocq S; Biran-Mucignat V; Boelle PY; Lebas F; Baudon JJ; Gold F
Arch Pediatr; 2006 Oct; 13(10):1299-304. PubMed ID: 16919922
[TBL] [Abstract][Full Text] [Related]
13. Caffeine therapy for apnea of prematurity.
Schmidt B; Roberts RS; Davis P; Doyle LW; Barrington KJ; Ohlsson A; Solimano A; Tin W;
N Engl J Med; 2006 May; 354(20):2112-21. PubMed ID: 16707748
[TBL] [Abstract][Full Text] [Related]
14. Caffeine versus theophylline for apnea in preterm infants.
Henderson-Smart DJ; Steer PA
Cochrane Database Syst Rev; 2010 Jan; (1):CD000273. PubMed ID: 20091506
[TBL] [Abstract][Full Text] [Related]
15. Caffeine citrate therapy for apnea of prematurity.
Johnson PJ
Neonatal Netw; 2011; 30(6):408-12. PubMed ID: 22052121
[No Abstract] [Full Text] [Related]
16. Long-term effects of caffeine therapy for apnea of prematurity.
Schmidt B; Roberts RS; Davis P; Doyle LW; Barrington KJ; Ohlsson A; Solimano A; Tin W;
N Engl J Med; 2007 Nov; 357(19):1893-902. PubMed ID: 17989382
[TBL] [Abstract][Full Text] [Related]
17. Caffeine citrate: a review of its use in apnoea of prematurity.
Comer AM; Perry CM; Figgitt DP
Paediatr Drugs; 2001; 3(1):61-79. PubMed ID: 11220405
[TBL] [Abstract][Full Text] [Related]
18. Caffeine Administration to Prevent Apnea in Very Premature Infants.
Armanian AM; Iranpour R; Faghihian E; Salehimehr N
Pediatr Neonatol; 2016 Oct; 57(5):408-412. PubMed ID: 26976495
[TBL] [Abstract][Full Text] [Related]
19. Periextubation caffeine in preterm neonates: a randomized dose response trial.
Steer PA; Flenady VJ; Shearman A; Lee TC; Tudehope DI; Charles BG
J Paediatr Child Health; 2003; 39(7):511-5. PubMed ID: 12969204
[TBL] [Abstract][Full Text] [Related]
20. Methylxanthine treatment for apnea in preterm infants.
Henderson-Smart DJ; Steer P
Cochrane Database Syst Rev; 2000; (2):CD000140. PubMed ID: 10796304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]